OSTEOPOROSIS AMONG MEN WITH PROSTATE CANCER DURING TREATMENT WITH ANDROGEN DEPRIVATION THERAPY

被引：0
|
作者：
Poulsen, Mads
Frost, Morten
Abrahamsen, Bo
Gerke, Oke
Walter, Steen
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.448
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP50-14
引用
收藏
页码：E677 / E678
页数：2
相关论文
共 50 条
  • [41] Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy
    Annie-Claude M. Lassemillante
    Suhail A. R. Doi
    John D. Hooper
    John B. Prins
    Olivia R. L. Wright
    Endocrine, 2015, 50 : 344 - 354
  • [42] Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy
    Lassemillante, Annie-Claude M.
    Doi, Suhail A. R.
    Hooper, John D.
    Prins, John B.
    Wright, Olivia R. L.
    ENDOCRINE, 2015, 50 (02) : 344 - 354
  • [43] The prevalence of osteoporosis in men with prostate cancer on androgen deprivation therapy: a systematic review and meta-analysis
    Lassemillante, Annie-Claude
    Hooper, John
    Prins, John
    Doi, Suhail
    Wright, Olivia
    BJU INTERNATIONAL, 2013, 112 : 35 - 35
  • [44] Two Elderly Men with Myasthenia Gravis during Androgen Deprivation Therapy for Prostate Cancer
    Kanazawa, Kazo
    Tomizawa, Yuji
    Iseki, Tatou
    Yokoyama, Kazumasa
    Hattori, Nobutaka
    INTERNAL MEDICINE, 2023, 62 (16) : 2413 - 2414
  • [45] Osteoporosis Management in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
    Ellen F. T. Yee
    Robert E. White
    Glen H. Murata
    Christine Handanos
    Richard M. Hoffman
    Journal of General Internal Medicine, 2007, 22 : 1305 - 1310
  • [46] Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy
    Yee, Ellen F. T.
    White, Robert E.
    Murata, Glen H.
    Handanos, Christine
    Hoffman, Richard M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (09) : 1305 - 1310
  • [47] Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer
    Gagliano-Juca, Thiago
    Pencina, Karol M.
    Ganz, Tomas
    Travison, Thomas G.
    Kantoff, Philip W.
    Nguyen, Paul L.
    Taplin, Mary-Ellen
    Kibel, Adam S.
    Li, Zhuoying
    Huang, Grace
    Edwards, Robert R.
    Nemeth, Elizabeth
    Basaria, Shehzad
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2018, 315 (06): : E1185 - E1193
  • [48] Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy
    Bruder, JM
    Ma, JZ
    Basler, JW
    Welch, MD
    UROLOGY, 2006, 67 (01) : 152 - 155
  • [49] Recommendations for use of zoledronic acid (Z) for prevention and treatment of osteoporosis in men on androgen deprivation therapy (ADT) for prostate cancer (PC)
    Pandya, M. B.
    Broderick, W.
    Campbell, S. C.
    Garewal, H.
    Friedman, N.
    Moritz, T.
    Reda, D.
    Bhoopalam, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] Androgen Deprivation Therapy as Primary Treatment for Prostate Cancer
    Cannata, Dara H.
    Kirschenbaum, Alexander
    Levine, Alice C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02): : 360 - 365
12345